• 1
    Bleyer A, Albritton KH, Ries LAG, Barr R. Introduction. In: W Archie Bleyer, Ronald D. Barr, eds. Cancer in adolescents and young adults. Heidelberg: Springer-Verlag, 2007. 126.
  • 2
    Bleyer A, O'Leary M, Barr RD, Ries LAG. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. Bethesda, MD: National Cancer Institute, 2006.
  • 3
    Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2009. Toronto: Canadian Cancer Society, 2009.
  • 4
    Barr R, Rogers P, Schacter B. What should the age range be for AYA oncology? J Adolesc Young Adult Oncol 2011; 1: 4.
  • 5
    Adolescent and Young Adult Progress Review Group. Closing the gap: research and cancer care imperatives for adolescents and young adults with cancer. Bethesda MD: Department of Health and Human Services, National Institutes of Health, National Cancer Institute and LIVESTRONG Young Adult Alliance, August 2006. Available at: Accessed on December 14, 2011.
  • 6
    Cancer Care Ontario: Cancer in Young adults in Canada. Toronto, Canada, 2006. Available at: Accessed on December 14, 2011.
  • 7
    Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer 2006; 106: 142530.
  • 8
    Bleyer A. Latest estimates of survival rates of the 24 most common cancers in adolescent and young adult Americans. J Adolesc Young Adult Oncol 2011; 1: 3742.
  • 9
    De P, Ellison LF, Barr RD, Semenciw R, Marrett LD, Wier HK, Dryer D, Gruenfeld E. Canadian adolescents and young adults with cancer: opportunities to improve co-ordination and level of care. Can Med Assoc J 2011; 183: E18794.
  • 10
    Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Delays in cancer diagnosis in under-insured young adults and older adolescents. Oncologist 2007; 12: 81624.
  • 11
    Bleyer WA, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and the criticality of clinical trials. Cancer 2006; 107( Suppl 7): 11014.
  • 12
    Downs-Canners S, Shaw PH. A comparison of clinical trial enrollment between adolescent and young adult oncology patients treated at affiliated adult and pediatric oncology centres. J Pediatr Hematol Oncol 2009; 31: 927929.
  • 13
    McTiernan A. Issues surrounding the participation of adolescents in clinical trials in the UK. Eur J Cancer Care 2003; 12: 2339.
  • 14
    Fern LA, Whelan JS. Recruitment of adolescents and young adults to cancer clinical trials—International comparisons, barriers and implications. Semin Oncol 2010; 37: e18.
  • 15
    Bleyer A. The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 2005; 35: 182217.
  • 16
    Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer 2005; 103: 18917.
  • 17
    Peppercorn JM, Weeks JC, Cook EF, Joffee S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 2004; 363: 26370.
  • 18
    Barr RD, Greenberg ML. Cancer surveillance and control in adolescents—similarities and contrasts between Canada and the United States. Pediatr Blood Cancer 2006; 46: 2737.
  • 19
    Paulussen S, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc ASCO 2003; 22: 816(abstract 3279).
  • 20
    Greenberg ML, Barr RD, DiMonte B, McLaughlin E, Greenberg C. Childhood cancer registries in Ontario Canada: lessons learned from a comparison of two registries. Int J Cancer 2003; 105: 8891.
  • 21
    Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Rarr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, et al. Long-term results of Dana Farber Cancer Institute ALL Consortium protocol for children with newly diagnosed acute lymphoblastic leukemia (1985–2000). Leukemia 2010; 24: 32034.
  • 22
    Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Coustan-Smith E Jeha S, Cheng C, Metzger ML, et al. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 2011; 29: 38691.
  • 23
    Mitchell AE, Scarcella DL, Rigutto GL, Thursfield VJ, Giles GG, Sexton M, Ashley DM. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 2004; 180: 5962.
  • 24
    Fern L, Davies S, Eden T, Feltbower R, Grant R, Hawkins M, Lewis I, Loucaides E, Rowntree C, Stenning S, Whelan J. Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer 2008; 99: 196774.
  • 25
    Ferrari A, Montello M, Budd T, Bleyer A. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 2008; 50: 11014.
  • 26
    National Institute for Clinical Excellence Guidance on Cancer Services. Improving outcomes in children and young people with cancer. London: NICE, 2005.
  • 27
    Barr R, Rogers P, Schacter B, eds. Adolescents and young adults with cancer: towards better outcomes in Canada. Cancer 2011; 117( Suppl): 2239354.
  • 28
    Fernandez C, Fraser GAM, Freeman C, Grunfeld E, Gupta A, Mery LS, DePauw S, Schacter B. Principles and recommendations for the provision of health care in Canada to adolescent and young adult-aged cancer patients and survivors. J Adolesc Young Adult Oncol 2011; 1: 539.